Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Retained Earnings (2021 - 2025)

Bioregenx (BRGX) has 5 years of Retained Earnings data on record, last reported at -$36.1 million in Q3 2025.

  • For Q3 2025, Retained Earnings fell 1857736.28% year-over-year to -$36.1 million; the TTM value through Sep 2025 reached -$36.1 million, down 1857736.28%, while the annual FY2024 figure was -$35.6 million, 184.17% down from the prior year.
  • Retained Earnings reached -$36.1 million in Q3 2025 per BRGX's latest filing, down from -$7222.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $618.0 in Q2 2024 and bottomed at -$36.1 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$10.5 million, with a median of -$3.4 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: soared 100.02% in 2024, then tumbled 36200957.58% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$2.8 million in 2021, then decreased by 4.19% to -$2.9 million in 2022, then tumbled by 329.04% to -$12.5 million in 2023, then crashed by 184.17% to -$35.6 million in 2024, then decreased by 1.48% to -$36.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$36.1 million in Q3 2025, -$7222.0 in Q2 2025, and -$35.8 million in Q1 2025.